LG 101506: RXR Modulator Workflows for Immuno-Oncology Resea
2026-06-03
LG 101506, a high-purity RXR modulator from APExBIO, empowers researchers to dissect nuclear receptor signaling in cancer and metabolism. This guide delivers actionable protocol enhancements, troubleshooting strategies, and translational insights for leveraging LG 101506 in advanced immunotherapy models.
EPZ5676 and DOT1L Inhibition: Advancing MLL Leukemia Researc
2026-06-02
Explore the mechanistic underpinnings and translational applications of EPZ5676—a highly potent and selective DOT1L inhibitor—in MLL-rearranged leukemia research. This article offers in-depth guidance for experimental design, critically assesses the competitive landscape, and integrates immunoepigenetic insights to chart new directions for translational scientists.
Vancomycin Hydrochloride in Antibiotic Resistance Assays
2026-06-02
Vancomycin hydrochloride stands at the forefront of antibiotic resistance testing, delivering precise inhibition of Gram-positive bacteria and enabling robust susceptibility workflows. Explore protocol optimizations, advanced use-cases, and troubleshooting strategies that empower microbiology labs to drive translational insights using this gold-standard glycopeptide antibacterial agent.
SP2509: Advancing Epigenetic Therapy in AML Research
2026-06-01
This thought-leadership article explores the mechanistic and translational significance of SP2509, a potent Lysine-specific demethylase 1 antagonist, in acute myeloid leukemia (AML) research. We connect emerging evidence from cancer epigenetics to strategic guidance for translational researchers, highlighting SP2509’s unique action on LSD1, its differentiation from traditional epigenetic modulators, and its potential to reshape preclinical and combinatorial cancer therapy strategies. Building on recent literature, including the interplay of chromatin modifiers and co-targeting strategies in oncology, we provide actionable insights that extend beyond standard product reviews.
Two Decades of Toremifene Data: Implications for Targeted En
2026-06-01
This review synthesizes 20 years of clinical evidence on toremifene, a selective estrogen receptor modulator, in hormone-sensitive breast cancer. Its nuanced comparison with aromatase inhibitors and biomarker-driven treatment strategies highlights evolving standards for personalized endocrine therapy.
Milk-Derived Vesicle Uptake in Intestinal Stem Cell Organoid
2026-05-31
This study establishes physiologically relevant porcine intestinal stem cell (ISC)-based organoid models to investigate the uptake and functional effects of milk-derived extracellular vesicles (MEV). Key findings reveal region-specific internalization mechanisms and highlight the importance of endocytosis pathways in vesicle uptake, providing new avenues for gut biology and translational research.
Neurotensin: Precision Neurotensin Receptor 1 Activator Work
2026-05-30
Neurotensin (CAS 39379-15-2) streamlines GPCR trafficking and miRNA regulation in gastrointestinal and CNS models, offering superior specificity and reproducibility. This guide delivers advanced workflows, spectral interference mitigation, and troubleshooting strategies to maximize assay fidelity and translational impact.
Vasopressin Analogues: Mechanistic Advances and Therapeutic
2026-05-29
The reference review systematically dissects the evolution of vasopressin analogues, with a focus on their structural modifications and multitarget clinical applications. It highlights the translational potential of agents like lypressin acetate for treating diabetes insipidus and emerging antiviral strategies, providing a mechanistic framework for future peptide-based therapies.
Recombinant Mouse SHH Protein: Benchmarks for Patterning Res
2026-05-29
Recombinant Mouse Sonic Hedgehog (SHH) is a validated morphogen for modeling developmental patterning and congenital malformations. Its standardized activity and species-specific effects make it indispensable for limb, brain, and urogenital studies. This article summarizes quantitative benchmarks, protocol parameters, and key misconceptions for SHH protein in research.
ABT-263 (Navitoclax): Senolytic Innovation in Melanoma Assay
2026-05-28
Explore the advanced use of ABT-263 (Navitoclax) in real-time senolytic and apoptosis assays for cancer biology, with a special focus on novel melanoma models. This article reveals practical insights from cutting-edge research and differentiates APExBIO’s offering in the evolving landscape.
O-GlcNAcylation Modulates Ferroptosis via HUWE1–TfR1 in Pree
2026-05-28
A recent study reveals that O-GlcNAc modification stabilizes HUWE1, promoting ubiquitination and degradation of the transferrin receptor TfR1, thereby suppressing ferroptosis and supporting trophoblast syncytialization in preeclampsia. These findings highlight the O-GlcNAc–HUWE1–TfR1 axis as a central regulator of placental stress and suggest new mechanistic targets for pregnancy disorder research.
Intestinal TM6SF2 Deficiency Drives MASH via Gut–Liver Axis
2026-05-27
This study demonstrates that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating host–microbe interactions. Deficiency of TM6SF2 in the intestinal epithelium triggers gut dysbiosis, barrier impairment, and pro-inflammatory signaling to the liver, highlighting new therapeutic targets for MASH.
PD 173074 in Pancreatic Cancer: Pathway Inhibition & Prognos
2026-05-27
Explore how PD 173074, a potent FGFR1/VEGFR2 inhibitor, advances pancreatic cancer research through pathway suppression and integration with pyroptosis-based prognostic models. Discover protocol guidance and translational perspectives unique to this article.
iPSC-Based Prescreening for Ultrarare Disease Clinical Trial
2026-05-26
Sequiera et al. introduce an induced pluripotent stem cell (iPSC) platform to personalize drug efficacy evaluation for ultrarare Leigh-like syndrome patients. Their approach enables functional prescreening of candidate therapeutics, improving the precision of clinical trial selection for individuals with novel genetic variants.
Neticonazole Hydrochloride: A New Paradigm in Antifungal and
2026-05-26
Explore the multifaceted role of Neticonazole Hydrochloride as a leading imidazole antifungal with unique exosome inhibition and apoptosis modulation properties relevant to colorectal cancer research. This in-depth analysis integrates clinical guidance and advanced translational workflow, offering practical insights not found in prior reviews.
466 records 17/32 page Previous Next First page 上5页 1617181920 下5页 Last page